Subject | Sex | Side | Largest nodule on U/S (cm) and side | Final pathology | Adverse pathological features |
---|---|---|---|---|---|
1 | F | R | 2.4 (right) | Medullary CA | |
2 | M | L | 1 (left) | Micropapillary CA | ETE |
3 | M | L | 1.2 (left) | Micropapillary CA | |
4 | M | L | 1.2 (left) | Papillary CA | |
5 | F | R | 1.4 (right) | Follicular adenoma | |
6 | M | R | 1.6 (left) | Papillary CA | |
7 | F | L | 1.9 (left) | Nodular hyperplasia | |
8 | F | L | 2.15 (left) | Papillary CA | |
9 | F | R | 2.3 (right) | Papillary CA | |
10 | F | L | 2.4 (midline) | Follicular adenoma | |
11 | F | L | 2.7 (left) | Micropapillary CA | |
12 | F | L | 3 (left) | Papillary CA | |
13 | F | L | 1.7 (left) | Papillary CA | |
14 | F | L | 3.5 (left) | Nodular hyperplasia | |
15 | F | R | Irregular, >3a | Papillary CA | ETE, PNI, LVI |
16 | M | L | 5.5 (left) | Papillary CA | |
17 | F | L | 6.5 (left) | Nodular hyperplasia | |
18 | F | R | 7.7a(right) | Papillary CA | |
19 | M | L | 9.1 (left) | Papillary CA | ETE, LVI |
20 | F | L | 7 (left) | Nodular hyperplasia | |
21 | M | L | 0.7 (left) | Micropapillary CA | |
22 | F | L | No imagingc | Osteosarcomab | |
23 | F | R | 1.5 (right) | Papillary CA | |
24 | F | L | No imagingc | Poorly differentiated CA | |
25 | F | L | No imagingc | Papillary (tall cell variant) CA | ETE, PNI, LVI |